Schizophrenia is neither purely genetic nor purely environmental. It emerges from the interaction of both, with inherited vulnerability accounting for roughly 80% of the variation in risk while environmental factors act as triggers that can push a predisposed brain toward illness. About 1 in 345 people worldwide develop schizophrenia, and understanding why requires looking at how genes and life experiences converge.
The Genetic Foundation
The strongest evidence for a genetic component comes from twin studies. Identical twins share 100% of their DNA, and when one twin has schizophrenia, the other develops it roughly 40 to 50% of the time. For fraternal twins, who share about half their genes, that concordance drops to 10 to 19%. First-degree relatives of someone with schizophrenia carry a 6.5% lifetime risk, compared to just under 1% in the general population.
But those twin numbers also reveal something important: if schizophrenia were entirely genetic, identical twins would match 100% of the time. The fact that more than half of identical co-twins never develop the disorder proves that genes alone are not enough.
Researchers have identified over 100 regions of the genome linked to schizophrenia risk, but no single gene comes close to causing the disorder on its own. Each variant contributes a tiny increase in vulnerability. One notable region involves the gene for the dopamine D2 receptor, which happens to be the primary target of antipsychotic medications. Still, individual gene variants have only modest effects and are not useful for predicting who will develop schizophrenia.
Environmental Risks Before Birth
Some of the most significant environmental risk factors take hold before a person is even born. Bacterial infections during pregnancy are associated with roughly a two-fold increase in the offspring’s risk of developing schizophrenia. In one study of mothers who already had a schizophrenia spectrum diagnosis, prenatal infections were linked to more than a three-fold increase in risk for their children. Infection with the parasite Toxoplasma gondii during pregnancy has also been consistently tied to higher schizophrenia rates in offspring.
Nutritional deficiency during pregnancy, obstetric complications like oxygen deprivation at birth, and inadequate maternal weight gain all appear to contribute as well. Newborns with very low vitamin D levels have roughly double the risk of eventually developing schizophrenia. These findings suggest that disruptions to early brain development create a biological vulnerability that may not become apparent for decades.
Childhood and Adolescent Risk Factors
After birth, two environmental factors stand out. People with a history of childhood trauma have nearly three times the risk of developing psychosis, and researchers estimate that eliminating childhood adversity could theoretically prevent about a third of psychosis cases. Urban living also carries elevated risk, likely through a combination of social stress, pollution, and reduced access to protective factors like green space and strong community ties.
Cannabis use during adolescence is another well-documented risk factor. A Swedish cohort study found that heavy cannabis use at age 18 increased the risk of later schizophrenia sixfold. A New Zealand study showed that people who used cannabis by age 15 were four times as likely to receive a psychosis-related diagnosis by age 26. Part of this association may reflect the fact that teens already showing early psychotic symptoms are more likely to use cannabis, but even after accounting for pre-existing symptoms, cannabis use still elevated risk, though by a smaller margin.
How Stress Bridges Genes and Environment
The dominant framework for understanding schizophrenia is called the diathesis-stress model: a person inherits a biological vulnerability (the diathesis), and environmental stressors activate it. The proposed mechanism involves the body’s stress response system. When someone with a genetic predisposition experiences significant stress, the resulting spike in the stress hormone cortisol disrupts dopamine signaling in the brain. Over time, repeated stress exposure can amplify this disruption enough to trigger a first episode of psychosis.
This model helps explain why schizophrenia typically emerges in late adolescence and the early twenties, a period marked by intense social stress, identity formation, and, for many, first exposure to substances like cannabis. It also explains why some people with strong genetic loading never develop symptoms: they may simply never encounter sufficient environmental triggers during the critical window.
What Happens in the Brain
Two chemical messaging systems are central to schizophrenia. Dopamine has long been the focus because all effective antipsychotic medications work by blocking dopamine receptors. Social isolation, migration, childhood trauma, and acute psychosocial stress have all been shown to increase dopamine activity in the brain’s reward and motivation circuits, linking environmental risk directly to the brain chemistry of psychosis.
Glutamate, the brain’s main excitatory chemical messenger, plays a complementary role. Several of the genetic variants linked to schizophrenia directly affect glutamate receptors or the machinery that supports glutamate signaling. When glutamate signaling is disrupted, it can in turn overstimulate the dopamine system, creating a feedback loop. Cannabis use has been shown to depress glutamate signaling in neurons derived from people with schizophrenia, offering one possible explanation for why the drug increases risk.
These chemical disruptions leave measurable physical traces. Ventricles (the fluid-filled spaces inside the brain) are roughly 130% of normal size in people with schizophrenia, reflecting a loss of surrounding brain tissue. Gray matter volume, particularly in the frontal and temporal regions responsible for reasoning and language, is reduced. Some of this enlargement is present at the first episode of illness, pointing to a developmental origin, while further changes accumulate over the course of the illness.
Epigenetics: Where Nature Meets Nurture
Perhaps the most compelling evidence that schizophrenia cannot be neatly divided into “nature” or “nurture” comes from epigenetics, the study of how environmental exposures change the way genes are read without altering the DNA sequence itself. One key mechanism involves chemical tags called methyl groups that attach to DNA and dial gene activity up or down. These tags shift in response to environmental exposures throughout life, from prenatal nutrition to childhood stress to drug use.
People with schizophrenia show altered patterns of these chemical tags across the genome. Because methylation influences how genes build and maintain brain structure, connectivity, and cognitive function, it represents a concrete molecular bridge between inherited risk and lived experience. Your genes set the range of possibilities; your environment helps determine where within that range you land.
Putting the Percentages in Perspective
Heritability estimates for schizophrenia hover around 80%, which sounds overwhelming but is frequently misunderstood. That figure describes how much of the variation in risk across a population can be attributed to genetic differences. It does not mean that any one person’s schizophrenia is “80% genetic.” A person with no family history can develop the disorder after sufficient environmental insults, and a person with an identical twin who has schizophrenia has better than even odds of never developing it themselves.
The practical takeaway is that schizophrenia requires both a biological predisposition and environmental activation in most cases. Genes load the gun; environment pulls the trigger. This is why prevention research increasingly focuses on modifiable risk factors like reducing childhood adversity, delaying adolescent cannabis use, improving prenatal care, and managing stress, especially in people with a known family history.